Get started
Author

Cynthia W. Buness

Observed names: Buness, Cynthia W., C. W. Buness, Cynthia Buness, Cynthia W Buness
ORCID: 0000-0001-8309-6914
Observed ORCID: 0000-0001-8309-6914
OpenAlex ID: A5002335377
Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis
2018 · J. L. Damman, E. A. Rodriguez, et al. · Alimentary Pharmacology & Therapeutics · 77
Open-label prospective therapeutic clinical trials: oral vancomycin in children and adults with primary sclerosing cholangitis
2020 · Ahmad Hassan Ali, Jennifer Damman, et al. · Scandinavian Journal of Gastroenterology · 69
Oral Vancomycin Therapy in a Child with Primary Sclerosing Cholangitis and Severe Ulcerative Colitis
2016 · Cynthia Buness, Keith D. Lindor, et al. · Pediatric Gastroenterology Hepatology & Nutrition · 24
Successful response of primary sclerosing cholangitis and associated ulcerative colitis to oral vancomycin may depend on brand and personalized dose: report in an adolescent
2020 · Cynthia W. Buness, Kevin M. Johnson, et al. · Clinical Journal of Gastroenterology · 20
Identifying a therapeutic window of opportunity for people living with primary sclerosing cholangitis: Embryology and the overlap of inflammatory bowel disease with immune-mediated liver injury
2024 · Richard Kellermayer, Marco Carbone, et al. · Hepatology · 17
Potential Association of Doxycycline With the Onset of Primary Sclerosing Cholangitis: A Case Series
2019 · James Gage Buness, Ahmad Hassan Ali, et al. · American Journal of Therapeutics · 7
Letter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis
2023 · Ahmad H. Ali, Cynthia W. Buness, et al. · Hepatology · 5
Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease – paving a path forward
2026 · Kevin M. Johnson, John Grady, et al. · Expert Review of Gastroenterology & Hepatology · 4
Comment on “Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis”
2025 · Richard Kellermayer, Peter Lewindon, et al. · Therapeutic Advances in Gastroenterology · 2
An ‘Adaptive Treatment Strategy’ for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis
2024 · Ayesha Shah, James Tabibian, et al. · Digestive Diseases and Sciences · 2
PDF
Letter to the Editor
2026 · Cynthia W. Buness, Steve Wadsworth, et al. · The American Journal of Gastroenterology
Advances in primary sclerosing cholangitis care
2026 · Kevin M Johnson, Richard Kellermayer, et al. · The Lancet
Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease – paving a path forward
2026 · Johnson, Kevin M., Grady, John, et al. · Figshare
Works count: 14
Citation count: 227
H-index: 6
I10-index: 5
Year
Topic
Type